Table 1.
Strain | Tumor Type | Time | Cell number | Injection site | Reference |
---|---|---|---|---|---|
Tg (fli1: eGFP) | Breast cancer | 2 dpf | 50 - 400 | duct of Cuvier | (37) |
Tg (fli1: eGFP) | glioblastoma | 30 dpf | 2×105 | cerebrum | (38) |
Tg (fli1: eGFP) | glioblastoma | 30 dpf | 2×105 | cerebrum | (38) |
Tg (fli1: eGFP) | neuroendocrine tumor | 2 dpf | 100 | perivitelline space | (39) |
Tg (fli1: eGFP) | pancreatic cancer | 2 dpf | 200 | yolk | (40) |
Tg (fli1: eGFP) | pituitary adenoma | 2 dpf | 100 | perivitelline space | (41) |
AB | rhabdomyosarcoma | >30 dpf | 2×104 | intraperitoneal cavity | (42) |
Casper | multiple myeloma | 2 dpf | 100 | perivitelline space | (43) |
ABTL, Albino, Casper, Tg (fli1: EGFP), Tg (mpo: GFP) |
ewing sarcoma | 2 dpf/30 dpf | 500 - 800 | yolk/eye | (44) |
Casper | leukaemia | 2 dpf | 25 – 50 | yolk | (45) |
AB, achesb55, mutant | liver cancer | 2 dpf | 300 | yolk | (46) |
AB, Casper | pancreatic | 2 dpf | 50 - 80 | yolk | (47) |
AB | Adrenocortical cancer | 2 dpf | 240 | yolk | (48) |
Tg (fli1: eGFP) | Adenocarcinoma of the lungs | 2 dpf | 200 - 300 | yolk | (49) |
Tg (fli1: EGFP) | Oral squamous cell carcinoma | 2 dpf | 50 | yolk | (50) |
Tg (Kdrl: mCherry) | liposarcoma | 2 dpf | 50 - 400 | heartbeat | (51) |